Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 32.85
-0.40 (-1.20%)
At close: Apr 2, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.8 billion as of April 2, 2026. Its market cap has decreased by -14.78% in one year.
Market Cap
4.80B
Enterprise Value
7.10B
Revenue
8.57B
Ranking
n/a
PE Ratio
13.80
Stock Price
32.85
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.80B, a decrease of -22.60%. That is a compound annual growth rate of -14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 4.80B | -1.65% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 234.57B |
| Caliway Biopharmaceuticals | 148.78B |
| Bora Pharmaceuticals | 57.02B |
| Lotus Pharmaceutical | 56.77B |
| OBI Pharma | 4.99B |
| Pharmosa Biopharm | 4.91B |
| Locus Cell | 4.80B |
| Bionime | 4.73B |